148 related articles for article (PubMed ID: 23072855)
21. Screening for pre-eclampsia early in pregnancy: performance of a multivariable model combining clinical characteristics and biochemical markers.
Giguère Y; Massé J; Thériault S; Bujold E; Lafond J; Rousseau F; Forest JC
BJOG; 2015 Feb; 122(3):402-10. PubMed ID: 25175335
[TBL] [Abstract][Full Text] [Related]
22. Added value of angiogenic factors for the prediction of early and late preeclampsia in the first trimester of pregnancy.
Crovetto F; Figueras F; Triunfo S; Crispi F; Rodriguez-Sureda V; Peguero A; Dominguez C; Gratacos E
Fetal Diagn Ther; 2014; 35(4):258-66. PubMed ID: 24714555
[TBL] [Abstract][Full Text] [Related]
23. Circulating angiogenic proteins in trisomy 13.
Bdolah Y; Palomaki GE; Yaron Y; Bdolah-Abram T; Goldman M; Levine RJ; Sachs BP; Haddow JE; Karumanchi SA
Am J Obstet Gynecol; 2006 Jan; 194(1):239-45. PubMed ID: 16389038
[TBL] [Abstract][Full Text] [Related]
24. Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation.
Spencer K; Yu CK; Savvidou M; Papageorghiou AT; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Jun; 27(6):658-63. PubMed ID: 16493628
[TBL] [Abstract][Full Text] [Related]
25. Competing risks model in screening for preeclampsia by serum placental growth factor and soluble fms-like tyrosine kinase-1 at 30-33 weeks' gestation.
Lai J; Garcia-Tizon Larroca S; Peeva G; Poon LC; Wright D; Nicolaides KH
Fetal Diagn Ther; 2014; 35(4):240-8. PubMed ID: 24853452
[TBL] [Abstract][Full Text] [Related]
26. First trimester PAPP-A levels correlate with sFlt-1 levels longitudinally in pregnant women with and without preeclampsia.
Saxena AR; Seely EW; Rich-Edwards JW; Wilkins-Haug LE; Karumanchi SA; McElrath TF
BMC Pregnancy Childbirth; 2013 Apr; 13():85. PubMed ID: 23557166
[TBL] [Abstract][Full Text] [Related]
27. [Modern methods of early screening for preeclampsia and pregnancy-induced hypertension--a review].
Poprawski G; Wender-Ozegowska E; Zawiejska A; Brazert J
Ginekol Pol; 2012 Sep; 83(9):688-93. PubMed ID: 23342898
[TBL] [Abstract][Full Text] [Related]
28. Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women.
Moore Simas TA; Crawford SL; Bathgate S; Yan J; Robidoux L; Moore M; Maynard SE
J Matern Fetal Neonatal Med; 2014 Jul; 27(10):1038-48. PubMed ID: 24066977
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis of preeclampsia with soluble Fms-like tyrosine kinase 1/placental growth factor ratio: an inter-assay comparison.
Andersen LB; Frederiksen-Møller B; Work Havelund K; Dechend R; Jørgensen JS; Jensen BL; Nielsen J; Lykkedegn S; Barington T; Christesen HT
J Am Soc Hypertens; 2015 Feb; 9(2):86-96. PubMed ID: 25600419
[TBL] [Abstract][Full Text] [Related]
30. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia.
Thadhani R; Mutter WP; Wolf M; Levine RJ; Taylor RN; Sukhatme VP; Ecker J; Karumanchi SA
J Clin Endocrinol Metab; 2004 Feb; 89(2):770-5. PubMed ID: 14764795
[TBL] [Abstract][Full Text] [Related]
31. Circulating angiogenic factors and preeclampsia.
Tsatsaris V; Goffin F; Foidart JM
N Engl J Med; 2004 May; 350(19):2003-4; author reply 2003-4. PubMed ID: 15128904
[No Abstract] [Full Text] [Related]
32. Plasma level of hydroxysteroid (17-β) dehydrogenase 1 in the second trimester is an independent risk factor for predicting preeclampsia after adjusting for the effects of mean blood pressure, bilateral notching and plasma level of soluble fms-like tyrosine kinase 1/placental growth factor ratio.
Ohkuchi A; Ishibashi O; Hirashima C; Takahashi K; Matsubara S; Takizawa T; Suzuki M
Hypertens Res; 2012 Dec; 35(12):1152-8. PubMed ID: 22786566
[TBL] [Abstract][Full Text] [Related]
33. Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction.
Vatten LJ; Åsvold BO; Eskild A
Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1388-94. PubMed ID: 22882089
[TBL] [Abstract][Full Text] [Related]
34. Angiogenic factors as diagnostic tests for preeclampsia: a performance comparison between two commercial immunoassays.
Benton SJ; Hu Y; Xie F; Kupfer K; Lee SW; Magee LA; von Dadelszen P
Am J Obstet Gynecol; 2011 Nov; 205(5):469.e1-8. PubMed ID: 21903191
[TBL] [Abstract][Full Text] [Related]
35. Serum soluble FMS-like tyrosine kinase 1 and placental growth factor concentration as predictors of preeclampsia in high risk pregnant women.
Hanita O; Alia NN; Zaleha AM; Nor Azlin MI
Malays J Pathol; 2014 Apr; 36(1):19-26. PubMed ID: 24763231
[TBL] [Abstract][Full Text] [Related]
36. First trimester pregnancy-associated plasma protein A and human chorionic gonadotropin-beta in early and late pre-eclampsia.
Karahasanovic A; Sørensen S; Nilas L
Clin Chem Lab Med; 2014 Apr; 52(4):521-5. PubMed ID: 24176962
[TBL] [Abstract][Full Text] [Related]
37. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
Govender N; Naicker T; Rajakumar A; Moodley J
Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
[TBL] [Abstract][Full Text] [Related]
38. Biomarkers in pre-eclampsia: a novel approach to early detection of the disease.
Masoura S; Kalogiannidis IA; Gitas G; Goutsioulis A; Koiou E; Athanasiadis A; Vavatsi N
J Obstet Gynaecol; 2012 Oct; 32(7):609-16. PubMed ID: 22943702
[TBL] [Abstract][Full Text] [Related]
39. Maternal plasma soluble fms-like tyrosine kinase-1 and free vascular endothelial growth factor at 11 to 13 weeks of gestation in preeclampsia.
Akolekar R; de Cruz J; Foidart JM; Munaut C; Nicolaides KH
Prenat Diagn; 2010 Mar; 30(3):191-7. PubMed ID: 20101671
[TBL] [Abstract][Full Text] [Related]
40. Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia.
Wikström AK; Larsson A; Eriksson UJ; Nash P; Nordén-Lindeberg S; Olovsson M
Obstet Gynecol; 2007 Jun; 109(6):1368-74. PubMed ID: 17540809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
